These data indicate that at the site of inflammation, when the disease is active or ACPA is positive, the proportion of Treg cells and Th1-like Treg cells decreases, correlating with increased inflammation and exacerbation of RA. This evidence concerns the gene PRTN3 and rheumatoid arthritis.